Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting ...

After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...

Despite decades of sun-smart education, the number of treatments for certain types of skin cancer is on the increase.

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The father of a woman whose death is being examined by prosecutors said a health board was "warned for years" about issues ...

Save this Michigan list for your next getaway, it is a reliable mix of nature and city stops you can revisit without getting ...

COHASSET, Minn. — Minnesota regulators gave Minnesota Power the green light to build a solar project that could power up to ...